Strong R&D investment, advanced manufacturing technologies, and supportive government policies accelerate global API production growth.Austin, Texas, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Small Molecule ...
With plans to expand its domestic active pharmaceutical ingredient (API) production in the U.S., AbbVie will invest $195 million to build a new manufacturing facility in North Chicago, Illinois. This ...
Lonza completed a laboratory expansion project at its API manufacturing facility in Nansha, China. The project, which grew the footprint of the lab by 250 square meters, included the addition of new ...
“Our customers, in partnership with federal and state agencies, are reshoring drug manufacturing in the U.S., the world’s largest pharmaceutical market. Local API production is vital for supply chain ...
Wuxi STA, a subsidiary of WuXi AppTec, continued its manufacturing expansion march with the opening of another high-potency active pharmaceutical ingredient (HPAPI) production facility in China. The ...
Cequence Security, the provider of unified API protection, is unveiling the latest testing capabilities—API Security Testing—for its unified API protection platform. Focused on pre-production ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback